Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (111-120 of 263) with videos related to

Pageof 27
Sort By:
European Journal of Clinical Pharmacology|March 22, 1976
Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsyM Eichelbaum, L Bertilsson, L Lund, et al.
European Annals of Allergy and Clinical Immunology|January 14, 2022
Qualitative and quantitative comparison of allergen component-specific to birch and grass analyzed by ImmunoCAP assay and Euroline immunoblot testM Berge, L Bertilsson, O Hultgren, et al.
Alimentary Pharmacology & Therapeutics|April 24, 1999
Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatmentM Sagar, I Janczewska, A Ljungdahl, et al.
Pharmacogenetics|June 1, 1995
Codeine metabolism in three Oriental populations: a pilot study in Chinese, Japanese and KoreansQ Y Yue, J O Svensson, J Säwe, et al.
Pharmacology & Toxicology|February 1, 1993
Polymorphism of debrisoquine and mephenytoin hydroxylation among EstoniansR A Kiivet, J O Svensson, L Bertilsson, et al.
Acta Psychiatrica Scandinavica|June 1, 1989
Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluidB Mårtensson, S Nyberg, G Toresson, et al.
Clinical Pharmacology and Therapeutics|June 19, 1998
Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodineN Brynne, P Dalén, G Alván, et al.
European Journal of Clinical Pharmacology|February 1, 1980
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineL Bertilsson, H J Dengler, M Eichelbaum, et al.
British Journal of Clinical Pharmacology|August 1, 1997
Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19L Bertilsson, G Tybring, J Widén, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Carbamazepine in trigeminal neuralgia: clinical effects in relation to plasma-concentrationT Tomson, G Tybring, L Bertilsson, et al.
Pageof 27

Showing results (111-120 of 263) with videos related to

Sort By:
Pageof 27
European Journal of Clinical Pharmacology|March 22, 1976
Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsyM Eichelbaum, L Bertilsson, L Lund, et al.
European Annals of Allergy and Clinical Immunology|January 14, 2022
Qualitative and quantitative comparison of allergen component-specific to birch and grass analyzed by ImmunoCAP assay and Euroline immunoblot testM Berge, L Bertilsson, O Hultgren, et al.
Alimentary Pharmacology & Therapeutics|April 24, 1999
Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatmentM Sagar, I Janczewska, A Ljungdahl, et al.
Pharmacogenetics|June 1, 1995
Codeine metabolism in three Oriental populations: a pilot study in Chinese, Japanese and KoreansQ Y Yue, J O Svensson, J Säwe, et al.
Pharmacology & Toxicology|February 1, 1993
Polymorphism of debrisoquine and mephenytoin hydroxylation among EstoniansR A Kiivet, J O Svensson, L Bertilsson, et al.
Acta Psychiatrica Scandinavica|June 1, 1989
Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluidB Mårtensson, S Nyberg, G Toresson, et al.
Clinical Pharmacology and Therapeutics|June 19, 1998
Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodineN Brynne, P Dalén, G Alván, et al.
European Journal of Clinical Pharmacology|February 1, 1980
Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineL Bertilsson, H J Dengler, M Eichelbaum, et al.
British Journal of Clinical Pharmacology|August 1, 1997
Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19L Bertilsson, G Tybring, J Widén, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Carbamazepine in trigeminal neuralgia: clinical effects in relation to plasma-concentrationT Tomson, G Tybring, L Bertilsson, et al.
Pageof 27